Global foreign direct investment (FDI) to developed economies declined by 21% in 2022, reflecting global economic and political instability, according to the UN Conference for Trade and Development (UNCTAD) World Investment Report, a flagship annual publication. 

Meanwhile, investment to developing economies rose by 7% overall, with the group accounting for a record two-thirds of all global FDI. Greenfield project announcements across these countries rose by 37% in number, almost doubling in value. 

FDI flows to developing Asia did particularly well, reaching a record $652bn in 2022 – 5% higher than the previous year – and accounting for almost half of global FDI. China remained the world’s second-largest host for FDI after the US. 

FDI in South Asia rose by 10% to $58bn. Flows to India – the largest country in the sub-region – rose by 12% to $50bn in terms of new greenfield project announcements (doubling to 1,008 projects, which makes it the third-largest recipient worldwide), while also rising 64% in international project finance deals to 187, thereby ranking the country second worldwide. 

Flows to Latin America and the Caribbean rose by 4%, reaching $202bn – thereby recovering 2020’s lost ground fully and reaching the second-highest level ever recorded. The rise of commodity prices pushed up reinvested earnings in Brazil to record levels. 

Following a record year in 2021, FDI to Africa fell by 44% to $45bn due to a single intra-company financial transaction in South Africa. Despite the decrease, flows into Africa in 2022 were similar to the ten-year average before 2021.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now